-
Bajaj Finance
1,151.20 1,151.20(%) -
Torrent Pharma.
5,139.30 5,139.30(%) -
Netweb Technol.
4,597.95 5,241.65(%) -
TVS Motor Co.
4,320.00 4,320.00(%) -
Rossell Techsys
979.95 1,111.00(%) -
Indo-MIM
815.90 815.90(%) -
Kaynes Tech
3,860.55 7,705.00(%) -
Hero Motocorp
5,397.80 6,390.00(%) -
63 Moons Tech.
949.65 1,029.35(%) -
Adani Ports
1,707.00 1,891.80(%) -
Shadowfax Technologies
253.35 253.35(%) -
Kalyan Jewellers
610.15 327.15(%) -
M & M
3,456.00 3,840.00(%) -
Tata Motors
440.40 508.95(%) -
HFCL
194.30 229.40(%) -
Hyundai Motor I
2,208.90 2,889.65(%) -
Swiggy
280.00 235.85(%) -
TBO Tek
1,565.80 1,764.00(%) -
Reliance Industries
1,309.30 1,611.20(%) -
Eicher Motors
7,795.00 5,390.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Suven Life Sciences Ltd Miscellaneous
- Indian Private
- BSE Code : 4916.0
- ISIN : INE495B01038
-
Today’s Low
297.60 -
Today’s High
310.00
-
Open
302.00 -
Perv Close
299.25 -
52W Low
124.11 -
52W High
371.00
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
8,677.50
-
Div & Yield %
0.00
-
Book Value(₹)
62.01
-
Debt-Equity Ratio
2.62
-
AGM Date
31-Jul-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
0.00
-
Mar.Cap (₹Cr.)
8,677.50
-
RONW (%)
0.00
-
ROCE (%)
0.00
Score Board
-
Equity (₹ in Cr.)
28.26
-
BV (₹)
62.00
-
Sales( ₹ in Cr.)
7.11
-
NP (in Cr.)
-54.86
-
NP Var(%)
-5.0
-
Div%
0.0
-
CPS (₹)
-1.70
-
EPS (₹)
-1.90
-
Traded Value (₹ in Lakhs)
8,677.50
-
52 Week High
371.00
-
52 Week Low
124.11
-
Price BSE
307.0
-
Price NSE
307.00
-
Market Capital( in Cr.)
8,677.50
-
P/C Ratio
-176.10
-
P/E Ratio
-158.10
-
Price Vs.BV
-1.90
-
30-Jul-2026( 05:09)
Corporate News - Suven... - Suven Life Sciences Limited wi...
-
30-Jul-2026( 01:45)
Corporate News - India... - The company’s Business Respons...
-
14-May-2026( 10:24)
Corporate News - Suven... - Suven Life Sciences announced...
-
13-May-2026( 03:13)
Results - Announcements - Suven... - Net Loss of Suven Life Science...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 6.66 | 11.69 | 13.54 | 11.84 | 13.48 | 14.41 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 6.66 | 11.69 | 13.54 | 11.84 | 13.48 | 14.41 |
| Other Income | 10.73 | 28.59 | 14.45 | 5.32 | 7.75 | 14.04 |
| Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 17.39 | 40.28 | 27.99 | 17.16 | 21.23 | 28.45 |
| EXPENDITURE : | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Power and Fuel Cost | 0.30 | 0.26 | 0.00 | 0.00 | 0.00 | 1.63 |
| Employee Cost | 20.82 | 16.53 | 15.77 | 17.46 | 15.29 | 14.60 |
| Other Manufacturing Expenses | 1.79 | 1.54 | 0.93 | 2.59 | 0.14 | 0.02 |
| Selling and Administration Expenses | 34.27 | 23.06 | 22.95 | 27.01 | 27.61 | 30.26 |
| Miscellaneous Expenses | 1.31 | 1.15 | 1.52 | 1.30 | 0.89 | 3.17 |
| Employee Benefit Expenses | 20.82 | 16.53 | 15.77 | 17.46 | 15.29 | 14.60 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 58.49 | 42.55 | 41.18 | 48.37 | 43.93 | 49.68 |
| Operating Profit | -41.11 | -2.27 | -13.18 | -31.22 | -22.70 | -21.23 |
| Interest | 0.15 | 0.24 | 0.40 | 0.64 | 0.91 | 0.54 |
| Gross Profit | -41.26 | -2.51 | -13.58 | -31.86 | -23.61 | -21.77 |
| Depreciation | 5.82 | 6.50 | 6.54 | 4.39 | 4.35 | 4.17 |
| Profit Before Tax | -47.08 | -9.01 | -20.12 | -36.25 | -27.96 | -25.94 |
| Current Tax | 0.00 | -1.00 | 0.00 | 0.00 | 0.38 | 2.28 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | -5.70 | -14.46 |
| Reported Net Profit | -47.08 | -8.01 | -20.13 | -36.25 | -22.63 | -13.75 |
| Extraordinary Items | 4.98 | 12.01 | 7.79 | 3.99 | 0.06 | 0.50 |
| Adjusted Net Profit | -52.06 | -20.02 | -27.92 | -40.24 | -22.69 | -14.25 |
| Adjustment below Net Profit | -0.06 | -0.06 | 0.19 | -0.15 | -0.31 | -0.30 |
| P & L Balance brought forward | 133.43 | 141.49 | 161.43 | 197.83 | 220.77 | 234.82 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 86.29 | 133.43 | 141.49 | 161.43 | 197.83 | 220.77 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -2.16 | -0.37 | -0.92 | -2.49 | -1.78 | -1.08 |
| Earnings Per Share(Adj)-Unit Curr | -2.16 | -0.37 | -0.92 | -2.29 | -1.64 | -1.00 |
| Book Value | 36.66 | 38.77 | 39.14 | 32.74 | 28.66 | 30.46 |
| Book Value(Adj)-Unit Curr | 36.66 | 38.77 | 39.14 | 30.17 | 26.41 | 28.07 |
